Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF OPERATIONS (Unaudited)

v3.21.1
CONDENSED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Product sales, net $ 4,844 $ 8,270
Cost of goods sold 2,486 4,262
Gross Profit 2,358 4,008
Operating expenses:    
Research and development 186 1,509
Selling, general and administrative 5,285 7,819
Total operating expenses 5,471 9,328
Operating Loss (3,113) (5,320)
Other Expenses [Abstract]    
Interest (income) expense, net 14 (10)
Income loss before income taxes (3,127) (5,310)
Income tax benefit 0 (158)
Net Loss $ (3,127) $ (5,152)
Weighted average common shares outstanding, basic and diluted (shares) 104,508 99,678
Net loss per common share, basic and diluted (in USD per share) $ (0.03) $ (0.05)
Revenue, Product and Service [Extensible List] us-gaap:ProductMember